3. Financial Institutions
  5. Thailand: Clarification on insurance companies' investment opportunities - Guidelines for investments in equity instruments

Thailand: Clarification on insurance companies' investment opportunities - Guidelines for investments in equity instruments

12 Sept 2023    4 minute read
Topics Insurance

In brief

Insurers are to be allowed to invest in equity instruments (i.e., shares) in other corporate entities, subject to certain rules and conditions, and where previously there was a lack of clarity on the approval process. The Office of Insurance Commission (OIC) has just issued three new guidelines to provide more clarity on approval for investment in the following:

  • Up to 10% of the total onshore equity instruments not traded on any local or international stock exchange, or offshore equity instruments of a foreign incorporated entity, issued by the target entity.
  • 20% or more of the total equity instruments of a licensed life insurance corporate broker (for investments by a licensed non-life insurer), or equity instruments of a licensed non-life insurance corporate broker (for investment by a licensed life insurer), issued by the target entity.
  • 20% or more of the total equity instruments of a company incorporated for the benefit of the insurance business as a whole, issued by the target entity.

Contents

In more detail

To be entitled to make these investments, the insurer must have the following qualifications:

To invest in up to 10% of the total onshore equity instruments not traded on any local or international stock exchange, or offshore equity instruments of a foreign incorporated entity

Qualifications of the insurer making the investment:

  • Capital Adequacy Ratio (CAR) not less than the minimum legal requirement.
  • Liquidity ratio (liquid assets per insurance reserve) not less than 110% for the last four consecutive quarters and throughout the period it holds the equity instruments.
  • Retained deficit of not more than half of the total equity.

In making the investment:

  • The insurer must provide supporting documents (e.g., corporate approval, details of the target company, cost-benefit analysis, feasibility study, valuation report) to seek OIC approval.
  • The OIC will consider the application within 30 days from receiving the application and all supporting documents.
  • The investment must not be for the purpose of circumventing the applicable investment requirements.
  • The insurer will need to explain the reasons and the necessity for making the additional investment.
To invest in 20% or more of the total equity instruments of a licensed life insurance corporate broker (for investment by a licensed non-life insurer), or equity instruments of a licensed non-life insurance corporate broker (for investment by a licensed life insurer)

Qualifications of the insurer making the investment:

  • CAR not less than the minimum legal requirement in the last four quarters.
  • Sufficient excess capital fund.
  • Liquidity ratio (liquid assets per insurance reserve) of not less than 110% for the last four consecutive quarters and throughout the period it holds the equity instruments.
  • Investment policy covering this specific investment.
  • Sufficient operational system, staff, administration, risk management, and relevant information.
  • Measures in place to prevent conflict of interest between the insurer making the investment and the target company. 
  • Retained deficit of not more than half of the total equity.

In making the investment:

  • The insurer must provide supporting documents (e.g., policy for investment in other businesses, corporate approval, objective, business operation of the target entity, business plan of the target entity, details of the investment ratio, cost-benefit analysis, feasibility study, valuation report, and insurance brokerage license of the target entity) to seek OIC approval.
  • The OIC will consider the application within 30 days from receiving the application and all supporting documents.
  • The OIC may impose conditions when granting approval, with which the insurer must comply.
  • The investment must not be for the purpose of circumventing the applicable investment requirements.
  • The insurer will need to explain the reasons and the necessity for making the additional investment.
To invest in 20% or more of the equity instruments of a company incorporated for the benefit of the insurance business as a whole

Key definition:

  • Business conducted for the benefit of the insurance business is defined as a business that contributes to the development, enhancement, provision of service, or facilitation of insurance companies or the insurance industry as a whole (e.g., providing services for actuarial insurance, claims management, insurance academic institutions, data collection and processing, and user identification).

Qualifications of the insurer making the investment:

  • CAR not less than the minimum legal requirement in the last four quarters.
  • Sufficient excess capital fund.
  • Liquidity ratio (liquid assets per insurance reserve) of not less than 110% for the last four consecutive quarters and throughout the period it holds the equity instruments.
  • Investment policy covering this specific investment.
  • Sufficient operational system, staff, administration, risk management, and relevant information.
  • Retained deficit of not more than half of the total equity.

In making the investment:

  • The insurer must provide supporting documents (e.g., policy for investment in other businesses, corporate approval, objective and business operation of the target entity, details and business plan of the target entity, cost-benefit analysis, feasibility study, and valuation report) to seek OIC approval.
  • The OIC will consider the application within 30 days from receiving the application and all supporting documents.
  • The OIC may impose conditions when granting approval, with which the insurer must comply.
  • The investment must not be for the purpose of circumventing the applicable investment requirements.
  • The insurer will need to explain the reasons and the necessity for making the additional investment.


Insurers that obtained OIC approval for investments in these equity instruments before 27 July 2023 can proceed with the investments under the approval granted. However, they should consider the applicable requirements under the new guidelines.

The new guidelines provide insurers with more clarity and certainty regarding criteria and the details to be presented to the OIC. Please contact us for more details of each investment criteria.

Contact Information
Sumet Orsirivikorn
Partner
Bangkok
Read my Bio
sumet.orsirivikorn@bakermckenzie.com
Amnart Pitakgorn
Partner
Bangkok
Read my Bio
amnart.pitakgorn@bakermckenzie.com
Jarae Sithiwong
Partner
Bangkok
Read my Bio
jarae.sithiwong@bakermckenzie.com
Sivapong Viriyabusaya
Partner
Bangkok
Read my Bio
sivapong.viriyabusaya@bakermckenzie.com
Ampika Kumar
Principal
Bangkok
Read my Bio
ampika.kumar@bakermckenzie.com

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.

HighQ
Copyright Baker McKenzie 2024 | Disclaimers | Supplemental Privacy Statement